Effects of Vitamin D on Skeletal Muscle Strength in Resistance Trained Adult Females

Sponsor
Auburn University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05489666
Collaborator
(none)
40
2
5

Study Details

Study Description

Brief Summary

The majority of vitamin D research has been done in non-athletic populations, particularly older populations, to analyze muscle weakness, pain, balance, and fractures. It has been reported that over a billion people worldwide are vitamin D deficient, including 36-70% of the young adult population. Previous literature also suggests that, even among healthy athletes, over 50% of subjects sampled had inadequate or insufficient vitamin D levels. Vitamin D deficiency can occur in young women, including pregnant women, and the risk of deficiency is even higher with advancing age in a woman's lifecycle. It is known that preserving skeletal muscle (SM) function is critical for women of all ages to prevent sarcopenia. Two factors in preserving SM are protein intake and resistance training. Relatively unknown are the actions of Vitamin D on SM function. Vitamin D deficiency can have a negative effect on SM function . However, additional research is needed to investigate the increase in SM strength when the serum concentration of vitamin D is improved. It is possible that an athlete may require an increased intake of vitamin D to assure adequate availability and storage for optimal performance; however, is known that food sources of vitamin D are limited in sufficient quantity to meet these requirements. Athletes who are insufficient will require a supplement of vitamin D3 for up to 5000 IU/day for at least eight weeks, to potentially reach optimal levels, then 1000-2000 IU/day for maintenance.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Nature Made Vitamin D3 5,000 IU, 125mcg
  • Dietary Supplement: Placebo
N/A

Detailed Description

The investigators seek to determine if women with a vitamin D serum concentration lower than 50 nmol/L and who regularly resistance train will improve strength performance outcomes when taking a daily supplement of 5000 IU of vitamin D3 over an 8-week period, as compared to the same demographic of women who do not take a daily supplement of vitamin D3. The participants will receive "Nature's Bounty Vitamin D3, 5,000 IU, soft gels" and the PI will be providing the supplement and the placebo. A pre-intervention data collection and screening (PRE) will be performed involving blood draw, food log, a body composition test (using Dual-energy X-ray absorptiometry [DEXA]), and a BioDex testing to determine maximal muscle strength. Following PRE testing, the participants will be divided into one of two groups: 1) taking a vitamin D3 supplement (n=20) or, 2) taking a placebo. The participants will be instructed to continue their resistance training regimen. Training will be logged and turned in to the PI weekly. The participants will perform a post-intervention data collection (POST), which includes the same test from PRE. Variables of interest will include changes in: 1) blood level of vitamin D, 2) muscle and fat mass, and 3) leg strength/power during the BioDex test.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
A two-arm parallel assignment; one group receives the treatment (vitamin D3 supplement 5,000IU/day) and one group receives the placebo (control).A two-arm parallel assignment; one group receives the treatment (vitamin D3 supplement 5,000IU/day) and one group receives the placebo (control).
Masking:
Double (Participant, Investigator)
Masking Description:
Double-blind masking; neither the investigator nor the participants will know, the assigned intervention placement.
Primary Purpose:
Basic Science
Official Title:
Effects of Vitamin D on Skeletal Muscle Strength in Resistance Trained Adult Females
Anticipated Study Start Date :
Sep 1, 2022
Anticipated Primary Completion Date :
Nov 30, 2022
Anticipated Study Completion Date :
Feb 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Treatment Group

Participants in this group will be administered an oral Vitamin D3 supplement; 5,000 IU/ day. The participants will take the supplement themselves, orally, once per day, for 8 weeks.

Dietary Supplement: Nature Made Vitamin D3 5,000 IU, 125mcg
Taking a 5,000 IU oral supplement of Vitamin D3, daily, for 8 weeks, may improve strength performance in women who have and are continuing a resistance trained workout regimen. After blood vitamin D levels have been raised to an optimal range, a lower dosage may be assigned as needed from 5,000 IU per day to 1,000-2,000 IU per day.
Other Names:
  • Spring Valley
  • Life Extensions
  • GNC
  • Nature's Bounty
  • CVSHealth
  • Swanson
  • Placebo Comparator: Control Group

    Participants in this group will be administered an oral, soft-gel, lookalike placebo. The participants will take the supplement themselves, orally, once per day, for 8 weeks.

    Dietary Supplement: Placebo
    Resistance trained women may not improve their strength performance with low levels of vitamin D in the blood.

    Outcome Measures

    Primary Outcome Measures

    1. Biodex Strength performance change [8 weeks]

      Taking a daily supplement of 5,000 IU of vitamin D3 may change strength outcomes measured in newton meters (Nm).

    Secondary Outcome Measures

    1. Serum 25(OH)D status [8 weeks]

      Taking a daily supplement of 5,000 IU of vitamin D3 may change blood levels of vitamin D.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    19 Years to 55 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion criteria will include:
    Participant will need to answer "yes" to the following items:
    1. female

    2. not pregnant

    3. between the ages of 19-55 years old

    4. a non-smoker

    5. currently resistance training (i.e., lifting weights) for more than 2 days/week for a minimum of > 24 months

    6. free of any known overt cardiovascular or metabolic disease

    7. not an active user of tanning beds

    8. not consuming now or haven't consumed within the last 6 months, a vitamin D or multivitamin supplement or a form of a supplement with vitamin D added

    9. not consuming now or haven't consumed within the last 2 months, agents that affect hormones (testosterone boosters, growth hormone boosters, etc.) (does not include birth control/oral contraceptives)

    10. not allergic to rubbing alcohol

    Exclusion criteria will include:
    1. Outside of study inclusion parameters

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Auburn University

    Investigators

    • Study Chair: Donna O Burnett, PhD, Auburn University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Nilophar Zandieh, MS, Principle Investigator, Auburn University
    ClinicalTrials.gov Identifier:
    NCT05489666
    Other Study ID Numbers:
    • 22-306
    First Posted:
    Aug 5, 2022
    Last Update Posted:
    Aug 10, 2022
    Last Verified:
    Aug 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Product Manufactured in and Exported from the U.S.:
    Yes
    Keywords provided by Nilophar Zandieh, MS, Principle Investigator, Auburn University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 10, 2022